News

Aziyo Biologics Announces Pricing of Initial Public Offering

SILVER SPRING, Md. , Oct. 07, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) today announced the pricing of its initial public offering of 2,941,176 shares of common stock, consisting of 2,205,882 shares of Class A common stock and 735,294 shares of Class B common stock, each at a...

Aziyo Biologics Announces Appointment of Chief Financial Officer

SILVER SPRING, Md., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today that Matthew Ferguson...

Aziyo Biologics Announces New Appointments to Board of Directors

SILVER SPRING, Md., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today that Maybelle Jordan,...

Aziyo Biologics Announces Launch of OsteGro® V

Expands Regenerative Medicine Product Portfolio and Leverages Proprietary Processing Platform to Protect and Preserve Native Bone Cells Silver Spring, Md. – June 29, 2020 –  Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage, regenerative medicine company creating the next generation of...